A study of 1 million diverse genomes identified mutations in FNIP1 linked to more muscle, less belly fat & lower blood sugar. Carriers had a 60% reduced risk of cardiometabolic disease, pointing to a possible drug target for diabetes + heart disease
nature.com/articles/d4158…
nature.com/articles/d4158…